OncoZenge Seeks Patent Protection for BupiZenge's Broader Oral Medical Use

MT Newswires · 2d ago
06:02 AM EDT, 09/11/2026 (MT Newswires) -- OncoZenge (ONCOZ.ST) said Friday it filed a new patent application in Sweden for BupiZenge's broader dental and oral medical use. The application was lodged with the Swedish Intellectual Property Office on Thursday, potentially expanding the product's intellectual property protection beyond the local delivery of the anesthetic bupivacaine for oral pain relief. The pharmaceutical company also plans to submit an international application from the Swedish filing within a 12-month period. The lozenge-based BupiZenge is currently in a phase 3 trial for the treatment of pain associated with oral mucositis in cancer supportive care.